A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma

Medizinische Universität Wien, Vienna

Sydney Cancer Centre, Camperdown

Monash Medical Centre, East Bentleigh

Columbia University Medical Center, New York

Helios Klinikum Bad Saarow, Bad Saarow

Pennsylvania Oncology Hematology Associates, Philadelphia

Fox Chase Cancer Center, Philadelphia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Skånes Universitetssjukhus, Lund

Medical University of South Carolina, Charleston

University of Miami - Sylvester Comprehensive Cancer Center, Miami

IRCCS Istituto Ortopedico Rizzoli, Bologna

Centre René Gauducheau, Saint-Herblain

Universitätsklinikum Essen, Essen

University of Michigan, Ann Arbor

Mayo Clinic, Rochester

Washington University in St. Louis, St Louis

Universitätsmedizin Mannheim, Mannheim

Centre Léon Bérard, Service d'Oncologie Médicale, Lyon

MD Anderson Cancer Center, Houston

University of Colorado Cancer Center, Aurora

(TGen) Translational Genomics Research Institute, Scottsdale

Sarcoma Oncology Center, Santa Monica

Institut de Cancérologie Gustave Roussy, Villejuif

OHSU Knight Cancer Institute, Portland

University of Washington - Seattle Cancer Care Alliance, Seattle

SI Russian Oncological Research Center, Moscow

Moscow n.a. P.A Herzen Oncology Research Institute of Rosmedtechnologies, Moscow

Dana-Farber Cancer Institute, Boston

Mount Sinai Hospital, Toronto

Leids Unversitair Medisch Centrum, Leiden

Radiumhospitalet, Oslo

Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie w Warszawie, Warsaw

Royal Orthopaedic Hospital, Birmingham

University College Hospital, London

Newcastle General Hospital, Newcastle upon Tyne